| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:08:08 -0700 |
| HMDB ID |
HMDB00239 |
| Secondary Accession Numbers |
|
| Metabolite Identification |
| Common Name |
Pyridoxine |
| Description |
The 4-methanol form of vitamin B6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. Although pyridoxine and Vitamin B6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). Pyridoxine is one of the compounds that can be called vitamin B6. Pyridoxine assists in the balancing of sodium and potassium as well as promoting red blood cell production. It is linked to cancer immunity and helps fight the formation of homocysteine. It has been suggested that Pyridoxine might help children with learning difficulties, and may also prevent dandruff, eczema, and psoriasis. In addition, pyridoxine can help balance hormonal changes in women and aid in immune system. Lack of pyridoxine may cause anemia, nerve damage, seizures, skin problems, and sores in the mouth. -- Wikipedia Deficiency, though rare because of widespread distribution in foods, leads to the development of peripheral neuritis in adults and affects the central nervous system in children (DOSE - 3rd edition). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine
- 2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine
- 2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine
- 3-Hydroxy-2-Picoline-4,5-dimethanol
- 3-Hydroxy-4,5-dimethylol-alpha-picoline
- 5-Hydroxy-6-methyl-3,4-pyridinedimethanol
- Adermine
- Gravidox
- Hydoxin
- Piridossina
- Piridoxina
- Pyridoxin
- Pyridoxine
- Pyridoxinum
- Pyridoxol
- Pyridoxolum
|
| Chemical Formula |
C8H11NO3 |
| Average Molecular Weight |
169.1778 |
| Monoisotopic Molecular Weight |
169.073893223 |
| IUPAC Name |
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol |
| Traditional IUPAC Name |
pyridoxine |
| CAS Registry Number |
65-23-6 |
| SMILES |
CC1=NC=C(CO)C(CO)=C1O |
| InChI Identifier |
InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3 |
| InChI Key |
LXNHXLLTXMVWPM-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aromatic Heteromonocyclic Compounds |
| Class |
Pyridines and Derivatives |
| Sub Class |
Pyridoxines |
| Other Descriptors |
- Pyridines and Derivatives
- Water-soluble vitamins(KEGG)
- a vitamin B6(Cyc)
- hydroxymethylpyridine(ChEBI)
- methylpyridines(ChEBI)
- monohydroxypyridine(ChEBI)
- vitamin B6(ChEBI)
|
| Substituents |
|
| Direct Parent |
Pyridoxines |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
Not Available
|
| Application |
Not Available
|
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
159 - 162 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
79 mg/mL |
Not Available |
| LogP |
-0.77 |
SANGSTER (1993) |
|
| Predicted Properties |
|
| Spectra |
|
| Gas-MS Spectrum |
| 1H NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum EI-B (HITACHI M-80) |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| [1H,1H] 2D NMR Spectrum |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
|
| Tissue Location |
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.025 (0.007-0.060) uM |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected but not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Male |
Normal
|
|
| Urine |
Detected and Quantified |
|
<1 nmol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected but not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Male |
Normal
|
|
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.119 +/- 0.038 uM |
Adult (>18 years old) |
Both |
Homozygous sickle cell disease
|
|
|
| Associated Disorders and Diseases |
| Disease References |
| Homozygous sickle cell disease |
- van der Dijs FP, Schnog JJ, Brouwer DA, Velvis HJ, van den Berg GA, Bakker AJ, Duits AJ, Muskiet FD, Muskiet FA: Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients. Am J Hematol. 1998 Nov;59(3):192-8.
Pubmed: 9798656
|
|
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| DrugBank Metabolite ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB000574 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
1025  |
| KEGG Compound ID |
C00314  |
| BioCyc ID |
CPD-455  |
| BiGG ID |
34590  |
| Wikipedia Link |
Pyridoxine  |
| NuGOwiki Link |
HMDB00239  |
| Metagene Link |
HMDB00239  |
| METLIN ID |
5245  |
| PubChem Compound |
1054  |
| PDB ID |
Not Available |
| ChEBI ID |
16709  |
| References |
| Synthesis Reference |
Itov, Z. I.; Stepanova, S. V.; El'yanov, B. S.; Gunar, V. I. Synthesis of pyridoxine under high pressure. Khimiko-Farmatsevticheskii Zhurnal (1987), 21(7), 858-62. |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
- Henderson JM, Codner MA, Hollins B, Kutner MH, Merrill AH: The fasting B6 vitamer profile and response to a pyridoxine load in normal and cirrhotic subjects. Hepatology. 1986 May-Jun;6(3):464-71.
Pubmed: 3710434
- Chiang EP, Selhub J, Bagley PJ, Dallal G, Roubenoff R: Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis. Arthritis Res Ther. 2005;7(6):R1404-11. Epub 2005 Oct 14.
Pubmed: 16277693
- Manyam BV, Ferraro TN, Hare TA: Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease. Brain Res. 1987 Apr 7;408(1-2):125-30.
Pubmed: 2885064
- Temesvari P, Szilagyi I, Eck E, Boda D: Effects of an antenatal load of pyridoxine (vitamin B6) on the blood oxygen affinity and prolactin levels in newborn infants and their mothers. Acta Paediatr Scand. 1983 Jul;72(4):525-9.
Pubmed: 6624427
- McCully KS: Homocysteine, vitamins, and prevention of vascular disease. Mil Med. 2004 Apr;169(4):325-9.
Pubmed: 15132238
- Chen S, Ito M, Saijo T, Naito E, Kuroda Y: Molecular genetic analysis of pyridoxine-nonresponsive homocystinuric siblings with different blood methionine levels during the neonatal period. J Med Invest. 1999 Aug;46(3-4):186-91.
Pubmed: 10687314
- Wasilewska A, Narkiewicz M, Rutkowski B, Lysiak-Szydlowska W: Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis? Med Sci Monit. 2003 Mar;9(3):CR147-51.
Pubmed: 12640345
- Kidd GS, Dimond R, Kark JA, Whorton N, Vigersky RA: The effects of pyridoxine on pituitary hormone secretion in amenorrhea-galactorrhea syndromes. J Clin Endocrinol Metab. 1982 Apr;54(4):872-5.
Pubmed: 6801073
- Plecko B, Stockler-Ipsiroglu S, Paschke E, Erwa W, Struys EA, Jakobs C: Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol. 2000 Jul;48(1):121-5.
Pubmed: 10894227
- Pirulli D, Marangella M, Amoroso A: Primary hyperoxaluria: genotype-phenotype correlation. J Nephrol. 2003 Mar-Apr;16(2):297-309.
Pubmed: 12768081
- Amoroso A, Pirulli D, Florian F, Puzzer D, Boniotto M, Crovella S, Zezlina S, Spano A, Mazzola G, Savoldi S, Ferrettini C, Berutti S, Petrarulo M, Marangella M: AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. J Am Soc Nephrol. 2001 Oct;12(10):2072-9.
Pubmed: 11562405
- Tolis G, Laliberte R, Guyda H, Naftolin F: Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes. J Clin Endocrinol Metab. 1977 Jun;44(6):1197-9.
Pubmed: 559690
- Esteve-Romero J, Capella-Peiro ME, Monferrer-Pons L, Gil-Agusti M: Micellar liquid chromatography in clinical chemistry: application to the monitorization of B6 vitamins. Clin Chim Acta. 2004 Oct;348(1-2):69-77.
Pubmed: 15369738
|